Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: Results of a pilot study

European Journal of Clinical Nutrition

Volumn 59, Issue 5, 2005, Pages 723-726

  Daubioul, C A ^a   Horsmans, Y ^b   Lambert, P ^a   Danse, E ^b   Delzenne, N M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Aminotransferases; Blood glucose; Fructans; Humans; Nonalcoholic steatohepatitis; Triacylglycerol

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FRUCTAN; GAMMA GLUTAMYLTRANSFERASE; INSULIN; LIPID; MALTODEXTRIN; OLIGOFRUCTOSE; RAFTILOSE P95; UNCLASSIFIED DRUG;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD ANALYSIS; BLOOD SAMPLING; BODY COMPOSITION; BODY FAT; CALORIC INTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FATTY LIVER; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; NONALCOHOLIC FATTY LIVER; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ASPARTATE AMINOTRANSFERASES; BIOPSY; BODY COMPOSITION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENERGY INTAKE; FATTY LIVER; GLUCOSE; HEPATITIS; HUMANS; INSULIN; LIPID METABOLISM; LIVER; MALE; MIDDLE AGED; OLIGOSACCHARIDES; PILOT PROJECTS; POLYSACCHARIDES; TIME FACTORS; TRANSAMINASES;

ANIMALIA;

EID: 19144365839     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1602127     Document Type: Article

References (18)

1. Agrawal S & Bonkovsky HL (2002): Management of nonalcoholic steatohepatitis: an analytic review. J. Clin. Gastroenterol. 35, 253-261.
2. Bergman RN, Van Citters GW, Mittelman SD, Dea MK, Hamilton-Wessler M, Kim SP & Ellmerer M (2001): Central role of the adipocyte in the metabolic syndrome. J. Investig. Med. 49, 119-126.
3. Brighenti E Casiraghi MC, Canzi E & Ferrari A (1999): Effect of consumption of a ready-to-eat breakfast cereal containing inulin on the intestinal motility and blood lipids in healthy male volunteers. Eur. J. Clin. Nutr. 53, 726-733.
4. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwandef-Tetri BA & Bacon BR (1999): Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 94, 2467-2474.
5. Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, Karim R, Lin R, Samarasinghe D, Liddle C, Weltman M & George J (2002): NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 35, 373-379.
6. Daubioul CA, Rousseau N, Demeure R, Gallez B, Taper HS, Declerck B & Delzenne NM (2002): Dietary fructans, but not cellulose, decrease triglyceride accumulation in the liver of obese Zucker fa/fa rats. J. Nutr. 132, 967-973.
7. Daubioul CA, Taper HS, De Wispelaere LD & Delzenne NM (2000): Dietary oligofructose lessens hepatic steatosis, but does not prevent hypertriglyceridemia in obese Zucker rats. J. Nutr. 130, 1314-1319.
8. Delzenne NM & Williams CM (2002): Prebiotics and lipid metabolism. Curr. Opin. Lipidol. 13, 61-67.
9. Diraison F, Moulin P & Beylot M (2003): Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non alcoholic fatty liver disease. Diabetes Metab. 29, 478-485.
10. Jackson KG, Taylor GR, Clohessy AM & Williams C (1999): The effect of daily intake of inulin on fasting lipid, insulin and glucose concentrations in middle-aged men and women. Br. J. Nutr. 82, 23-30.
11. Kok N, Roberfroid M & Delzenne N (1996): Dietary OFS modifies the impact of fructose on hepatic triacylglycerol metabolism. Metabolism 45, 1547-1550.
12. Letexier D, Diraison F & Beylot M (2003): Addition of inulin to a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans. Am J. Clin. Nutr. 77, 559-564.
13. Luyck FH, Lefebvre PJ & Scheen AJ (2000): Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab. 26, 98-106.
14. Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, Cassader M, David E, Cavallo-Perin P & Rizzetto M (2002): Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome : further evidence for an etiologic association. Hepatology 35, 367-372.
15. Reid AE (2001): Nonalcoholic steatohepatitis. Gastroenterology 121, 710-723.
16. Roberfroid MB & Delzenne NM (1998): Dietary fructans. Annu. Rev. Nutr. 18, 117-143.
17. Yu AS & Keeffe EB (2002): Nonalcoholic fatty liver disease. Rev. Gastroenterol. Disord. 2, 11-19.
18. Zafrani ES (2004): Non-alcoholic fatty liver disease: an emerging pathological spectrum. Virchows Arch. 444, 3-12.